Ivermectin—a drug and a tool

European Journal of Clinical Microbiology & Infectious Diseases volume 39, pages599–600(2020)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

US$ 39.95

Tax calculation will be finalised during checkout.

References

  1. 1.

    Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS (2017) European guideline for the management of scabies. Eur Acad Derma Venerol. https://doi.org/10.1111/jdv.14351

  2. 2.

    Fox LAM (2006) Ivermectin: uses and impact 20 years on. Curr Opin Infect Dis 19:588–593

    Article  Google Scholar 

  3. 3.

    Weigl JAI (2018) Outbreaks of scabies in schools and use of Ivermectin (German). Das Gesundheitswesen 80:360–364

    Article  Google Scholar 

Download references

Author information

Affiliations

  1. Public Health Institute Ploen, Hamburgerstr. 17/18, 24306, Ploen, Schleswig-Holstein, Germany

    Josef A. I. Weigl

Authors
  1. Josef A. I. Weigl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Josef A. I. Weigl.

Ethics declarations

Conflict of interest

The author declares that there is no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Weigl, J.A.I. Ivermectin—a drug and a tool. Eur J Clin Microbiol Infect Dis 39, 599–600 (2020). https://doi.org/10.1007/s10096-019-03806-6

Download citation